Varex Imaging Co. (NASDAQ:VREX) Shares Bought by US Bancorp DE

US Bancorp DE lifted its stake in shares of Varex Imaging Co. (NASDAQ:VREX) by 149.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 7,386 shares of the company’s stock after purchasing an additional 4,429 shares during the quarter. US Bancorp DE’s holdings in Varex Imaging were worth $108,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in VREX. Pzena Investment Management LLC grew its stake in Varex Imaging by 51.4% in the 3rd quarter. Pzena Investment Management LLC now owns 3,890,879 shares of the company’s stock valued at $46,379,000 after acquiring an additional 1,321,666 shares during the last quarter. Wellington Management Group LLP acquired a new stake in shares of Varex Imaging in the third quarter worth approximately $19,801,000. Geode Capital Management LLC boosted its position in shares of Varex Imaging by 0.5% in the third quarter. Geode Capital Management LLC now owns 929,004 shares of the company’s stock worth $11,076,000 after acquiring an additional 4,211 shares during the last quarter. Jane Street Group LLC lifted its position in Varex Imaging by 230.6% during the third quarter. Jane Street Group LLC now owns 551,157 shares of the company’s stock valued at $6,570,000 after buying an additional 384,448 shares in the last quarter. Finally, Rice Hall James & Associates LLC lifted its position in Varex Imaging by 240.7% during the fourth quarter. Rice Hall James & Associates LLC now owns 328,692 shares of the company’s stock valued at $4,796,000 after buying an additional 232,229 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Oppenheimer reduced their price target on shares of Varex Imaging from $30.00 to $23.00 and set an “outperform” rating on the stock in a research report on Friday, February 7th. B. Riley reiterated a “buy” rating and set a $22.00 target price (up previously from $21.00) on shares of Varex Imaging in a research note on Friday, February 7th. Finally, StockNews.com upgraded shares of Varex Imaging from a “hold” rating to a “buy” rating in a research note on Friday, February 7th.

Varex Imaging Stock Performance

Shares of VREX opened at $12.50 on Monday. The company has a market cap of $515 million, a price-to-earnings ratio of -10.68 and a beta of 0.56. The firm has a fifty day moving average of $13.39 and a 200-day moving average of $13.41. Varex Imaging Co. has a 1 year low of $10.19 and a 1 year high of $18.30. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.50 and a current ratio of 4.36.

Varex Imaging (NASDAQ:VREX) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.03. Varex Imaging had a negative net margin of 5.79% and a positive return on equity of 4.00%. As a group, equities analysts anticipate that Varex Imaging Co. will post 0.53 earnings per share for the current year.

Varex Imaging Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.